Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the Big Pharma team up with Profluent to ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
New technology enables the insertion of a large segment of DNA into a genome, potentially expanding gene therapy treatment ...
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
With Phase 3 data in hand, Intellia Therapeutics is seeking approval for its in vivo CRISPR gene editing therapy for ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...
Topline results from the pivotal HAELO trial demonstrate that a single infusion of lonvo-z significantly reduces HAE attacks and the need for chronic prophylactic therapy.
Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox ...
Colossal Biosciences has begun genome editing in its bid to resurrect the bluebuck, an African antelope hunted to extinction around 1800. Using DNA from a preserved specimen and the roan antelope as ...
How do our genes determine our appearance and our susceptibility to disease? This question is central to biomedical research, ...